|FDA approves inhalable diabetes drug Afrezza
The Food and Drug Administration on Friday said that it has approved a long-delayed inhalable diabetes medication, designed to help patients control their blood sugar levels.
|FDA clears robotic legs for some paralyzed people
Federal health regulators on Thursday approved a first-of-a-kind set of robotic leg braces, that can help some disabled people walk again. The system functions like an exoskeleton for people paralyzed from the waist down.
|FDA To Ban Artery-Clogging Trans Fats
Heart-clogging trans fats have been slowly disappearing from grocery aisles and restaurant menus in the last decade. Now, the Food and Drug Administration is finishing the job.
|FDA warns of allergic reactions with acne products
Federal health officials are warning consumers who use anti-acne treatments about rare, but potentially deadly, allergic reactions that can cause swelling of the face and difficulty breathing.
|Heart pacer-zapper benefits women more, FDA says
Women with heart failure are less likely to get a special kind of pacemaker than men, but are more likely to benefit from the device, a new analysis by the Food and Drug Administration suggests.
|FDA Warning on Jerky Treats for Dogs
The FDA says jerky treats have caused illness and deaths in hundreds of dogs.
|Potentially Counterfeit Or Unsafe Botox Shipped To Kentucky
Federal regulators have warned more than 350 medical practices, including six in Kentucky, that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.
|FDA: Plan B One-Step Approved For Sale To All Women
The US Food and Drug Administration approved the sale of Plan B One-Step to any woman regardless of her age. The emergency contraceptive, also known as the “Morning After Pill” will be sold over-the-counter. Video
|Attorney General Conway urges FDA to make generic pain pills harder to abuse
Prescription drug abuse is an epidemic that kills more than 1,000 Kentuckians each year
|FDA Approves Anti-Obesity Pill
Belviq is the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. Video